Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
22,051,850
-
Share change
-
-1,124,143
-
Total reported value
-
$20,286,716
-
Put/Call ratio
-
3.7%
-
Price per share
-
$0.92
-
Number of holders
-
48
-
Value change
-
-$802,406
-
Number of buys
-
15
-
Number of sells
-
20
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2024
As of 31 Mar 2024,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,051,850 shares.
The largest 10 holders included
BVF INC/IL, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ALETHEA CAPITAL MANAGEMENT, LLC, Point72 Asset Management, L.P., 5AM Venture Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Schonfeld Strategic Advisors LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.